Hudson Bay Capital Management
SNDX icon

Hudson Bay Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Hudson Bay Capital Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-62,330
Closed -$1.46M – 1669
2026
Q1 		$1.46M Sell
62,330
-102,670
-62% -$2.23M 0.01% 825
2025
Q4 		$3.47M Sell
165,000
-85,000
-34% -$1.48M 0.01% 596
2025
Q3 		$3.85M Sell
250,000
-193,300
-44% -$2.53M 0.01% 621
2025
Q2 		$4.15M Buy
443,300
+193,300
+77% +$2.13M 0.01% 593
2025
Q1 		$3.07M Sell
250,000
-86,000
-26% -$1.21M 0.01% 723
2024
Q4 		$4.44M Sell
336,000
-89,000
-21% -$1.52M 0.02% 525
2024
Q3 		$8.18M Buy
+425,000
New +$8.78M 0.03% 324
2023
Q4 		– Sell
-1,236,186
Closed -$17.9M – 876
2023
Q3 		$17.9M Buy
1,236,186
+761,186
+160% +$14.4M 0.14% 98
2023
Q2 		$9.94M Buy
+475,000
New +$9.89M 0.07% 178
2021
Q1 		– Sell
-160,000
Closed -$3.56M – 939
2020
Q4 		$3.56M Sell
160,000
-115,000
-42% -$2.38M 0.04% 286
2020
Q3 		$4.06M Buy
275,000
+54,700
+25% +$834K 0.06% 261
2020
Q2 		$3.26M Buy
+220,300
New +$3.36M 0.06% 254

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Hudson Bay Capital Management's SNDX Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Syndax Pharmaceuticals (SNDX) in Q2 2026, closing a stake of 62,330 shares — an estimated $1.46M sold.

Hudson Bay Capital Management first reported a position in SNDX in Q2 2020 and held it in 12 quarters. The position peaked at $17.9M in Q3 2023. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Syndax Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 62,330 Syndax Pharmaceuticals shares in Q2 2026, an estimated $1.46M.
  • Hudson Bay Capital Management first reported a position in Syndax Pharmaceuticals in Q2 2020 and held it in 12 quarters.
  • Hudson Bay Capital Management's Syndax Pharmaceuticals position peaked at $17.9M in Q3 2023.
  • 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.